Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Citric Acid Cycle: Overview01:37

The Citric Acid Cycle: Overview

In aerobic organisms, the citric acid cycle is the second stage of cellular respiration wherein molecules derived from the breakdown of carbohydrates, proteins, and fats are oxidized into carbon dioxide and energy. This process is also known as the tricarboxylic acid (TCA) cycle as the first product of the cycle, citric acid, contains three carboxyl groups in its structure. Alternatively, this cycle is also referred to as the Krebs cycle, in honor of its discoverer Sir Hans Krebs.
The citric...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
The Citric Acid Cycle02:36

The Citric Acid Cycle

The citric acid cycle, also known as the Krebs cycle or TCA cycle, consists of several energy-generating reactions that yield one ATP molecule, three NADH molecules, one FADH2 molecule, and two CO2 molecules.
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embracing Good Practices of Confirmatory Studies.

Kidney & blood pressure research·2026
Same author

Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series.

Drug target insights·2025
Same author

Obesity and Kidney Disease: A Focus on Ciliopathies.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2025
Same author

Genome-Based Advances in Modeling Renal Ciliopathies and Enhancing Patient Care.

Kidney & blood pressure research·2025
Same author

CFHR5 Nephropathy Case Report: A Novel Variant Characterized by Tubulointerstitial Kidney Disease.

Kidney & blood pressure research·2025
Same author

Hyperphagia in Bardet-Biedl syndrome: Pathophysiology, burden, and management.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2025

Related Experiment Video

Updated: Jun 5, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

Low urinary citrate: an overview.

Miriam Zacchia1, Patricia Preisig

  • 1Department of Nephrology, Second University of Naples, Naples, Italy. miriamzacchia@virgilio.it

Journal of Nephrology
|December 21, 2010
PubMed
Summary

Hypocitraturia, or low urinary citrate, increases kidney stone risk. Acid-base balance significantly impacts citrate levels by affecting its reabsorption and metabolism in the kidneys.

Area of Science:

  • Nephrology
  • Biochemistry
  • Urology

Background:

  • Hypocitraturia is a significant risk factor for kidney stone formation.
  • Urinary citrate plays a crucial role in preventing calcium stone development by forming soluble calcium-citrate complexes.
  • Ingested citrate is rapidly metabolized, with plasma levels showing little variation, thus not significantly influencing urinary citrate excretion.

Purpose of the Study:

  • To elucidate the physiological mechanisms governing urinary citrate excretion.
  • To understand the role of acid-base status in regulating citrate transport and metabolism.
  • To identify key factors influencing hypocitraturia and calcium stone risk.

Main Methods:

  • The study focuses on the physiological regulation of urinary citrate excretion.

More Related Videos

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation
08:08

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation

Published on: August 21, 2012

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Related Experiment Videos

Last Updated: Jun 5, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation
08:08

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation

Published on: August 21, 2012

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

  • Investigated the roles of NaDC1 cotransporter in citrate absorption and proximal tubule cell metabolism.
  • Examined the influence of acid-base status on citrate transport and enzymatic metabolism (ATP citrate lyase, m-aconitase).
  • Main Results:

    • Urinary citrate excretion is primarily determined by reabsorption from the glomerular filtrate and proximal tubule cell metabolism.
    • Acid-base status is the key physiological determinant, modulating NaDC1 activity and citrate-metabolizing enzymes.
    • Acid loads up-regulate both transport and metabolism, leading to hypocitraturia; alkaline loads primarily affect mitochondrial metabolism, increasing citrate excretion.

    Conclusions:

    • Urinary citrate levels are tightly regulated by kidney function and acid-base balance.
    • Understanding these mechanisms is crucial for managing hypocitraturia and reducing kidney stone formation.
    • Targeting citrate transport and metabolism represents a potential therapeutic strategy for kidney stone prevention.